Lupin Limited has informed the Exchange regarding a press release dated Jun 23, 2023, titled "Lupin Launches Rufinamide Oral Suspension in the United States.".
Lupin Limited has informed the Exchange regarding a press release dated Jun 23, 2023, titled "Lupin Launches Rufinamide Oral Suspension in the United States.".